CVS to pay $315M to settle opioid prescribing allegations

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 14 Oct, 14:45 UTC

Prosecutors say the company filled unnecessary prescriptions that fueled the opioid epidemic. A spokesperson for CVS said the company admitted to no wrongdoing and “strongly disagreed” with the case’s claims.